Juniper Breeze Liquid Antimicrobial
Benzalkonium Chloride
Hillyard Gmp
Human Otc Drug
NDC 76402-418Juniper Breeze Liquid Antimicrobial also known as Benzalkonium Chloride is a human otc drug labeled by 'Hillyard Gmp'. National Drug Code (NDC) number for Juniper Breeze Liquid Antimicrobial is 76402-418. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Juniper Breeze Liquid Antimicrobial drug includes Benzalkonium Chloride - .13 g/100mL . The currest status of Juniper Breeze Liquid Antimicrobial drug is Active.
Drug Information:
| Drug NDC: | 76402-418 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Juniper Breeze Liquid Antimicrobial |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Benzalkonium Chloride |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Hillyard Gmp |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | BENZALKONIUM CHLORIDE - .13 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Mar, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333E |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Hillyard GMP
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 1046593
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0780458010805
0780458010812
|
| UPC stands for Universal Product Code. |
| UNII: | F5UM2KM3W7
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 76402-418-02 | 3 BOTTLE, PLASTIC in 1 CARTON (76402-418-02) / 1000 mL in 1 BOTTLE, PLASTIC | 01 Mar, 2020 | N/A | No |
| 76402-418-03 | 4 BOTTLE, PLASTIC in 1 CARTON (76402-418-03) / 1250 mL in 1 BOTTLE, PLASTIC | 01 Mar, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antimicrobial
Product Elements:
Juniper breeze liquid antimicrobial benzalkonium chloride benzalkonium chloride benzalkonium water cocamidopropylamine oxide glycerin propanediol benzyl alcohol phenoxyethanol cetrimonium chloride laurtrimonium chloride dihydroxyethyl cocamine oxide glycereth-17 cocoate aloe vera leaf citric acid monohydrate
Indications and Usage:
Uses ⢠helps reduce bacteria that potentially can cause disease ⢠helps prevent cross-contamination by hand contact
Warnings:
Warnings ⢠for external use only ⢠do not contaminate water, food or feed by storage and disposal. keep out of reach of children. ⢠in case of eye contact, flush with water for 15 minutes. if irritation persists, get medical attention. in case of accidental ingestion, seek medical attention or contact a poison control center immediately.
Dosage and Administration:
Directions ⢠apply soap to palm of hand. ⢠lather and scrub hands (including fingers, wrist, and cuticles) vigorously for 60 seconds. ⢠rinse with water until all soap is removed from hands. ⢠dry completely (incomplete drying may lead to chapped skin). ⢠children under 6 years of age should be supervised when using this product.
Package Label Principal Display Panel:
Principal display panel â 1 liter hillyard juniper breeze liquid antimicrobial hand soap hil0041802 affinity touch-free place cartridge into dispenser, label facing back, and gently push pump into receiver until it clicks into place. to remove the cartridge and pump, rotate the green ring clockwise and pull the pump out. hillyard industries, inc. po box 909 st. joseph, mo 64502-0909 telephone: 816-233-1321 www.hillyard.com net contents 33.8 fl oz or 1 l peel here label image-01
Principal display panel â 1.25 liter hillyard juniper breeze liquid antimicrobial hand soap hil0041803 affinity dispensing system place cartridge into dispenser, label facing back, and gently push pump into receiver until it clicks into place. to remove the cartridge and pump, rotate the green ring clockwise and pull the pump out. hillyard industries, inc. po box 909 st. joseph, mo 64502-0909 telephone: 816-233-1321 www.hillyard.com net contents 42.3 fl oz or 1.25 l peel here label image-02